In what has become a seemingly weekly ritual, a series of problems cropped up across the city during the morning rush, including signal issues and a train with mechanical problems.
NYS Entity Status
NYS Filing Date
JANUARY 17, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - NICE & EASY DISCOUNT 99 & UP INC.
AROUND THE WEB
- Subway Delays, Again, Disrupt Commutes; L.I.R.R. Will Offer Some Discounts
By EMMA G. FITZSIMMONS - Tuesday Jun 20, 2017
- Lawsuit Claims Uber Is “99.9% Inaccessible” To People With Mobility Disabilities
By Mary Beth Quirk - Tuesday Jul 18, 2017
How hard is it for someone to get a wheelchair-accessible Uber in New York City? According to a new lawsuit, it’s pretty much impossible.Nonprofit legal center Disability Rights Advocates filed a class action lawsuit [PDF] on behalf of a coalition of disability groups and disabled individuals in New York City, claiming that the ride-hailing service is 99.9% …
- Dollar Stores Go Corporate As Big Chains Put Indie Discounters Out Of Business
By Laura Northrup - Thursday Jul 13, 2017
Across the country, the Dollar Store Wars mean that the national chains Dollar Tree, Dollar General, Family Dollar, and Dollar Express are fighting it out across the country for customers’ affection and brand loyalty. National chains have taken over just about every other retail category, so will independent dollar stores be able to survive?The New York Times looked into …
- Ralph Lauren’s stock up as preppy label reins in discounts
By Reuters - Tuesday Aug 8, 2017
Ralph Lauren reported better-than-expected quarterly profit and sales as the luxury apparel maker kept a tight leash on discounting and inventory, sending its shares up 5 percent in premarket trading. Ralph Lauren, like other US apparel chains, has been struggling with weak sales due to sluggish spending on clothing and accessories and fierce competition from...
- Abbvie’s hep C drug pricing threatens Gilead’s dominance
By Max Nisen - Tuesday Aug 8, 2017
Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.
- Fake Discount Clubs Took $42M From People Who Never Signed Up
By Mary Beth Quirk - Wednesday Aug 16, 2017
Discount clubs that give you savings on stuff you might want could be convenient, if you’re into that kind of thing. But not so much if you’ve never signed up for the service in the first place — and end up getting charged for it nonetheless.According to a complaint [PDF] filed by the Federal Trade Commission, starting …